At the residence of Puvvada Lakshmana, stocks of four Suspected Spurious Drugs were detected and seized during the raid.
The details are as follows:
1. Tazloc-CT 6.25 (Telmisartan and Chlorthalidone Tablets)
Batch No. M241009, Mfg. Dt. Aug-2024, Exp. Dt. July-2026, Claimed as Manufactured by: The Madras Pharmaceuticals, Karapakkam, Chennai, Claimed as marketed by USV Pvt. Ltd., Mumbai
2. Dapacose-10 Tablets (Dapagliflozin Tablets 10 mg)
Batch No. YTQD24010, Mfg. Dt. Aug-2024, Exp. Dt. July-2026, Claimed as Manufactured by: Innova Captab Ltd., Solan, Himachal Pradesh, Claimed as marketed by J.B. Chemicals & Pharmaceuticals Ltd., Mumbai
3. Dapacose-5 Tablets (Dapagliflozin Tablets 5 mg)
Batch No. YTQS24004, Mfg. Dt. June-2024, Exp. Dt. May-2026, Claimed as Manufactured by: Innova Captab Ltd., Solan, Himachal Pradesh, Claimed as marketed by J.B. Chemicals & Pharmaceuticals Ltd., Mumbai
4. Clear-Kit Tablets (Combipack of Mifepristone and Misoprostol Tablets)
Batch No. MHT25038, Mfg. Dt. Mar-2025, Exp. Dt. Feb2027, Claimed as Manufactured by: Maxcare Laboratories Pvt. Ltd., Dehradun, Uttarakahnd, Claimed as marketed by Medley Pharmaceuticals Ltd., Mumbai.
Sri. G. Prasad, Assistant Director, Rangareddy, Smt. D. Saritha, Assistant Director, Secunderabad, Sri. G. Anil, Drugs Inspector, Malakpet, Sri. B. Govind Singh, Drugs Inspector, Secunderabad, and Sri. M. Surendranath, Drugs Inspector, Begumpet, were among the officers who carried out the raid.
DCA officers lifted the samples for analysis. Further investigation will be carried out, and appropriate action will be taken as per the law against all the offenders involved. Spurious drugs pose a major threat to public health. They place the patient’s health at grave risk, as such drugs not only fail to cure the disease but, over time, can lead to disastrous consequences for the patient.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.